Creative Medical Technology Holdings to be Keynote Speaker at Gathering of Health Care Innovators

Thursday, April 12, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

The Company's Stem Cell Therapies to be Main Subject at Dr. James Veltmeyer's Congressional Health Care Symposium

SAN DIEGO, April 12, 2018 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. (OTCQB-CELZ) announced today it

will be giving the Keynote Address at the Veltmeyer Health Care Innovations Symposium April 12th, 2018 in San Diego, CA.  The Symposium is a gathering of medical practitioners, health care administrators, biotech investors, and other professionals, aimed at reducing cost and increasing efficiency of the Health Care System.

"Companies like Creative Medical Technology Holdings are pioneering innovative approaches that address the root cause of disease, using adult stem cells, in contrast to the majority of approaches which treat symptoms and not causes," said Dr. James Veltmeyer, Congressional Candidate for the 52nd District and Organizer of the Symposium. "In order to cause change in the currently ineffective Health Care System, we need to support and accelerate clinical translation of regenerative medicine approaches.  I applaud Creative Medical Technology Holdings for using adult stem cell therapy, and going through appropriate clinical trials and peer reviewed scientific processes in development of their clinical and commercialized stem cell technologies."

Creative Medical Technology Holdings has commercialized CaverStem™, a patented, adult stem cell procedure in the urology space.  Additionally, the Company is developing its technology licensed from the University of California San Diego in the area of neurodegeneration through its subsidiary CerebroStem LLC and its issued StemSpine patent on the treatment of degenerative disc disease with the use of adult stem cells.

"We are proud to be invited to speak at such a prestigious gathering of Health Care professionals and present our journey from bench to bedside in the area of adult stem cells," said Timothy Warbington, President and CEO of Creative Medical Technology Holdings. "We thank Dr. Veltmeyer for organizing the Symposium and supporting the area of Regenerative Medicine, which we all believe will play a major role in addressing the current Health Care Crisis."

Dr. Veltmeyer was chosen as "Top Doctor" of San Diego and has received numerous endorsements including from State Senator Joel Anderson and Dr. Peter Farrell, Founder and Chairman of Resmed Inc., the manufacturers of CPAP devices with a current market capitalization of $14 billion.

About Creative Medical Technology Holdings

Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company currently trading on the OTCQB under the ticker symbol CELZ. For further information about the company go to www.creativemedicaltechnology.com. For more information on our CaverStem procedure please go to www.caverstem.com. 

Forward-Looking Statements

OTC Markets has not reviewed and does not accept responsibility for the adequacy or accuracy of this release. This news release may contain forward-looking statements including but not limited to comments regarding the timing and content of upcoming clinical trials and laboratory results, marketing efforts, funding, etc. Forward-looking statements address future events and conditions and, therefore, involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements. See the periodic and other reports filed by Creative Medical Technology Holdings, Inc. with the Securities and Exchange Commission and available on the Commission's website at www.sec.gov.

Related Linkshttp://www.creativemedicaltechnology.comhttp://www.veltmeyerforcongress.com/

 

Cision View original content:http://www.prnewswire.com/news-releases/creative-medical-technology-holdings-to-be-keynote-speaker-at-gathering-of-health-care-innovators-300629147.html

SOURCE Creative Medical Technology Holdings, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store